Viewing Study NCT04005066


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2025-12-25 @ 10:24 PM
Study NCT ID: NCT04005066
Status: COMPLETED
Last Update Posted: 2022-12-19
First Post: 2019-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IV Study of ElunateĀ® (Fruquintinib) in Chinese Patients
Sponsor: Hutchmed
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module